Response to pazopanib‐based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma
Abstract Angiogenesis inhibitors (AGI) are not presently used for the treatment of gastric cancers. This report demonstrates that angiogenesis inhibitor can be safely and effectively used in combination with cytotoxic anti‐cancer agents for treatment of Gastric cancers.
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Wiley
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/65674c3e054d4917ac8f5a42efa27c35 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|